Adobe Stock 178314176 Salmon

StofnFiskur rebrands to Benchmark Genetics Iceland HF

As of 19th of January 2021, StofnFiskur hf is changing its legal name to Benchmark Genetics Iceland hf as a step in the single-brand strategy of the Benchmark Holdings plc group. StofnFiskur still remains the brand to be used for the Atlantic salmon breeding programme and strain operated by the Icelandic company.

New milestone in a long line of history

Founded in 1991, Benchmark Genetics Iceland is a long-established and trusted provider of improved genetic material to the salmon farming industry in Europe and Chile. With operations located in the southwest corner of Iceland, the structure consists of two separate broodstock facilities, an incubation center, and a family production unit.

The new Head Office is located in Hafnarfjordur, next to the capital Reykjavik. In addition to Atlantic salmon, the company also holds a facility for lumpfish juveniles, a complementary product used by salmon farmers for sea lice control.

The name change adds a new milestone in the company’s history and follows the acquisition in 2014 by the listed UK based group, Benchmark Holdings plc. Although the company’s legal name has changed, the enterprise registration number, company structure, and ownership remain the same.

1

Jonas Jonasson, CEO of Benchmark Genetics Iceland hf at the new Head Office, located in Hafnarfjordur, next to the capital Reykjavik.

Bg Instagram Post Images Jonas

Building for the future

Benchmark Genetics Iceland is continuing its growth and development. It will soon start constructing a new incubation station in Vogarvik, and later this year a new facility for family production. These investments will further strengthen the operations in Iceland.

Jonasson says: “I am very excited to be leading the company into a new era. The name change is a visible symbol of the major commercial and innovation steps we have taken since we joined Benchmark in November 2014.”

“Now, we are looking forward to completing the construction of the incubation station by June this year. The state-of-the-art facility will enable us to significantly increase the all-year-round supplies of biosecure ova to our worldwide customer base including our new customers in the growing land-based industry.”, ends Jonas Jonasson.

For more information, please contact Jonas Jonasson, CEO of Benchmark Genetics Iceland hf: e-mail: [email protected] and tel: +354 693 6306

25.01.2021

main.css loaded. 12:50 PM